Samsara Vision, a company dedicated to restoring vision and independence to patients suffering from late-stage age-related macular degeneration (AMD) through advanced visual prosthetic devices, has successfully completed its first SING…
GRO Biosciences Inc. (“GRObio”), a pioneering biotechnology firm utilizing synthetic biology to enhance the amino acid repertoire and advance protein therapeutics, has successfully concluded an oversubscribed Series B financing round,…
Bristol Myers Squibb (NYSE: BMY) has announced that the European Medicines Agency (EMA) has validated its Type II variation application for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a potential first-line…
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), unveiled new four-year findings from the RHONE-X extension study today. The study successfully met all primary endpoints, underscoring…
Research findings published today in the peer-reviewed Journal of Clinical Oncology by NMDP℠ and CIBMTR® (Center for International Blood and Marrow Transplant Research®) indicate that there is no significant difference…
Diakonos Oncology Corporation (“Diakonos”), a pioneer in immuno-oncology, announced today that its dendritic cell vaccine (DCV) for pancreatic ductal adenocarcinoma has received Fast Track designation from the U.S. Food and…
Spotlight Medical, a pioneering startup developing AI-driven prognosis tests to assist physicians in selecting the most effective treatment for cancer patients, has secured €6.2 million in seed funding. The investment…
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that the first patient has been dosed in a Phase 1/2 trial…
Pint Pharma is pleased to announce that ORLADEYO® (berotralstat) has been approved by the General Directorate of Medicines, Supplies and Drugs (DIGEMID) in Peru for daily oral use in the…
Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi” or “Company”), a clinical-stage biotechnology firm pioneering targeted virotherapies, has confirmed that its Board of Directors has sanctioned a reverse stock split of…
Neuranics, a Glasgow-based deep tech startup, celebrates winning the Deep Tech Investment of the Year award at the UK Angel Investment Awards. The ceremony took place at the Science Museum…
The “Worldwide Market for Clinical Laboratory Services, 9th Edition” has been newly listed on ResearchAndMarkets.com. Gain insights into demographic and disease trends, new developments, company performance, mergers and acquisitions, and…